| Literature DB >> 25763193 |
Sadaf Alipour1, Azin Saberi2, Akram Seifollahi3, Nooshin Shirzad4, Ladan Hosseini1.
Abstract
BACKGROUND: Several studies indicated that there is a high prevalence of vitamin D deficiency in Middle East countries.Entities:
Keywords: Deficiency; Iran; Prevalence; Vitamin D
Year: 2014 PMID: 25763193 PMCID: PMC4329745 DOI: 10.5812/ircmj.15461
Source DB: PubMed Journal: Iran Red Crescent Med J ISSN: 2074-1804 Impact factor: 0.611
Common Characteristics of the Participants[a]
| Mean | Min | Max | CI 95% | |
|---|---|---|---|---|
|
| 43.5 | 16 | 83 | 42.5-44.5 |
|
| 26.6 | 16.03 | 43.34 | 26.37-26.97 |
|
| 2.4 | 0 | 14 | 2.30-2.60 |
|
| ||||
| Menopausal status | ||||
| Menopause | 140 (26) | |||
| Premenopause | 398 (74) | |||
| Vitamin consumption | ||||
| Yes | 108 (20.1) | |||
| No | 430 (79.9) |
a Abbreviation: BMI, body mass Index
Prevalence of Vitamin D Deficiency in Different Age, Menopausal and Body Mass Index Groups[a,b]
| NL | Insuf | Def | Sev def | |
|---|---|---|---|---|
|
| ||||
| ≤ 39 | 5 (2.9) | 3 (1.7) | 20 (11.4) | 147 (84) |
| 40-49 | 14 (6.8) | 15 (7.3) | 29 (14.1) | 147 (71.7) |
| 50-60 | 21 (17.8) | 16 (13.6) | 36 (30.5) | 45 (38.1) |
| ≥ 60 | 10 (25) | 9 (22.5) | 8 (20) | 13 (32.5) |
|
| ||||
| No | 23 (5.8) | 22 (5.5) | 57 (14.3) | 296 (74.4) |
| Yes | 27 (19.3) | 21 (15) | 36 (25.7) | 56 (40) |
|
| ||||
| < 18.5 | 0 | 0 | 1 (11.1) | 8 (88.9) |
| 18.5-24.9 | 8 (6.8) | 9 (7.6) | 21 (17.8) | 80 (67.8) |
| 25-29.9 | 30 (9) | 29 (8.7) | 50 (15) | 224 (67.3) |
| ≥ 30 | 12 (15.4) | 5 (6.4) | 21 (26.9) | 40 (51.3) |
a Data are presented as No. (%).
b Abbreviations: NL, Normal (VitD > 35 ngr/mL); Insuf, Vitamin D insufficiency (35 < VitD < 25); Def, Vitamin D deficiency (VitD < 25 ngr/mL); Sev def, Severe vitamin D deficiency (VitD < 12.5 ngr/mL); BMI, body mass index.
Association of Vitamin D Deficiency by Principal Characteristics: Adjusted and Unadjusted Results (Multivariable and Univariable Model)[a,b,c]
| Variable | Crude OR | Adjusted OR |
|---|---|---|
|
| ||
| OR | 0.93 | 0.96 |
| 95%CI | 0.91-0.96 | 0.93-0.99 |
| P Value | < 0.001 | 0.03 |
|
| ||
| OR | 3 | 2.67 |
| 95%CI | 1.6-5.5 | 1.40-5 |
| P Value | < 0.001 | 0.003 |
|
| ||
| OR | 1 | 1 |
|
| ||
| OR | 0.25 | 0.46 |
| 95%CI | 0.14-0.46 | 0.21-0.99 |
| P Value | < 0.001 | 0.04 |
|
| ||
| OR | 1 | 1 |
|
| ||
| OR | 0.9 | 0.93 |
| 95%CI | 0.84-0.98 | 0.85-1.01 |
| P Value | 0.01 | 0.08 |
|
| ||
| OR | 0.84 | 0.9 |
| 95%CI | 0.73-0.91 | 0.7-0.1 |
| P Value | 0.02 | 0.5 |
a Abbreviation: OR, odd ratio; BMI, body mass index.
b Variables entered on step 1: age, menopaus al status, consumption of multivitamin supplements, parity, BMI.
c Variables entered on step 2: age, menopaus al status, consumption of multivitamin supplements, BMI.